FCI Ophthalmics Launches EzyPor Polyethylene Orbital Implant in the US

FCI Ophthalmics announced the launch of EzyPor in the United States. EzyPor is a polyethylene orbital implant with a proprietary suturing platform that is suggested for enucleation, evisceration, and secondary implantation. Ezypor is developed with a smooth anterior suturing surface and eight suture tunnels to allow for a variety of suturing options.

EzyPor Polyethylene Orbital Implant is a revolutionary new product designed to improve the effectiveness of orbital surgery. This implant is made of Ultra High Molecular Weight PolyEthylene (UHMWPE), a type of plastic that is highly resistant to wear and tear, making it an ideal choice for medical implants.

One of the key features of the EzyPor implant is its porosity, which ranges between 40% and 60%. This allows for the optimum colonization of fibrovascular tissue, helping to speed up the healing process and minimize the risk of complications.

In addition to its porous structure, the EzyPor implant also features an innovative and patented smooth anterior suturing platform. This platform makes it easier for surgeons to suture the implant in place, improving the accuracy and precision of the surgery.

The EzyPor implant also has eight suture tunnels, which help to facilitate needle insertion and muscle fixation. This makes it easier for surgeons to secure the implant in place, ensuring that it remains stable and secure during the healing process.

One of the main advantages of the EzyPor implant is that it does not require an autologous graft or wrapping material. This means that it can be used in a wider range of patients, including those who may not be suitable for other types of orbital implants.

The EzyPor implant is also sterile, ensuring that it is safe and hygienic to use.

Learn more about EzyPor at https://fci-ophthalmics.com/.